Pros | - | ![]() 3Y returns in the top 25% of the category. ![]() Larger AUM within category. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | - |
INDMoney rank | - | 7/23 | ||
Category,Subcateogry | Equity,Global - Other | Equity,Global - Other | ||
Fund Age | 3 Years | 12 Years | ||
Fund Size | 1738 Cr | 3019 Cr | ||
Min Investment | SIP ₹5000 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.67% | 1.25% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | NYSE FANG+ TR USD | S&P 500 TR USD |
No of Holdings | - | 64 | ||
Top 5 Holdings | - | Huntington Ingalls Industries Inc (3.13%) West Pharmaceutical Services Inc (2.98%) Corteva Inc (2.94%) Zimmer Biomet Holdings Inc (2.73%) Brown-Forman Corp Registered Shs -B- Non Vtg (2.71%) | ||
No of Sectors | - | 9 | ||
Top 3 Sectors | - | Health (25.97%) Tech (21%) Industrial (14.36%) | ||
Equity % | - | 98.41% | ||
Debt % | - | - | ||
P/E | 33.72 | 23.71 | ||
P/B | 11.75 | 3.23 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -6.9% | -10.86% | ||
3-Month Return | -16.47% | -16.03% | ||
6-Month Return | 18.42% | -15.31% | ||
1-Year Return | 16.99% | -3.39% | ||
3-Year Return | 35.87% | 7.57% | ||
5-Year Return | - | 13.35% |
Sharpe | 0.92 | 0.25 | ||
Alpha | 9.23 | -3.29 | ||
Beta | 0.8 | 1.04 | ||
Standard Deviation | 28.2 | 18.84 | ||
Information Ratio | 0.37 | -0.48 |
Description | Mirae Asset NYSE FANG+ ETF Fund of Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential US Bluechip Equity Fund Direct Plan Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Ekta Gala | Ritesh Lunawat |